The scale doesn't always tell the whole story, and success looks different for everyone
Safety profiles for once-weekly Ozempic (semaglutide) injection and once-daily Ozempic pill (semaglutide) injection and once-daily Ozempic pill Safety and tolerability evaluated across clinical trials Rates of GI symptoms across placebo-controlled trials with Ozempic injection and semaglutide tablets 1,2,a The most common adverse reactions reported in 5% of patients taking Ozempic injection and Ozempic tablets are nausea, vomiting, diarrhea, abdominal pain, and constipation
Pregnancy and breastfeeding: GLP-1 medications are not recommended during pregnancy or while breastfeeding
CM-A has received consulting fees from Sanofi, Novo Nordisk, AstraZeneca, Behringer Ingelheim and Eli Lilly
2021;20(7):e13382
However, its long-term success depends heavily on getting enough protein and nutrients during treatment